莱普通过抑制p38-MAPK信号通路来减少LPS诱导的A1反应性星球细胞激活和炎症
Meiqi Sun1, Yiqun Song1, Xiaoxuan Hu1,2
1Department/Institute of Neurobiology, School of Basic Medical Science, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Glia
|September 23, 2024
概括
莱普通过抑制神经毒性A1星球细胞和减少促炎性细胞因子来防止炎症. 这项研究证明了勒普的有效性.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 神经毒性A1反应性星体细胞是炎症反应的关键参与者.
- 勒因其神经保护作用而闻名,但其在传染性炎症诱导的A1星细胞激活中的作用尚不清楚.
- 了解瘦素对A1星球细胞的影响对于开发抗神经炎症的新治疗策略至关重要.
研究的目的:
- 在体外和体内研究丁对脂聚糖 (LPS) 诱导的A1星球细胞激活的作用.
- 探索潜在的信号通路,特别是p38-MAPK和NF-κB,参与勒的作用.
- 评估勒普丁作为治疗神经炎症的治疗剂的潜力.
主要方法:
- 用LPS刺激初级大鼠星球细胞培养物诱导炎症,随后进行丁治疗.
- 通过测量基因表达 (C3,H2-D1,H2-T23,Serping 1) 和促炎性细胞因子分泌 (IL-6,TNF-α) 来评估A1星球细胞激活.
- 在LPS诱导的动物模型中分析了信号通路激活 (-p38,-NF-κB p65) 和体内效应.
主要成果:
- 在LPS刺激下,显著提高了A1天体细胞特异性基因和促炎性细胞因子的调节,证实了天体细胞的激活.
- 莱普治疗剂量依赖地逆转了LPS诱导的A1星细胞激活,并降低了炎症性细胞因子水平.
- 莱普抑制了p38-MAPK和NF-κB信号通路的激活,并改善了体内疾病行为和炎症.
结论:
- 莱普有效地抑制LPS诱导的神经毒性A1天体细胞激活和神经炎症.
- 该机制涉及抑制p38-MAPK信号通路.
- 莱普显示了治疗神经炎症疾病的治疗潜力.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Inflammation
53.2K
Overview
53.2K


